- Hypothesis
- Open Access
- Published:
A proposed mechanism for progesterone regulation of trophoblast MMP2 transcription independent of classical progesterone response elements on its promoter
Journal of Experimental & Clinical Assisted Reproduction volume 3, Article number: 4 (2006)
Abstract
Background
Progesterone receptor act as ligand-inducible transcription factor in the respective target cells by binding to specific progesterone response elements in the promoter of the target genes. However, despite the lack of the classical progesterone response elements on matrix-metalloproteinase-2 promoter, progesterone has been shown to decrease the activity of this promoter
Presentation of the hypothesis
It has recently been suggested that in addition to interacting with their classical co-activators and co-repressors, progesterone receptor are capable of binding to several transcription factors. By interacting with other classes of transcription factors, progesterone receptor is capable of transcriptional activation through the transcription factors cognate DNA binding site.
Testing the hypothesis
Exploring transcription factors and transcription binding sites, interacting with the progesterone receptor in modulation of the matrix-metalloproteinase promoter.
Implications of the hypothesis
Identification of additional endogenous progesterone target genes makes it possible to further explore the signaling mechanisms by which the hormone regulates biological actions. Furthermore, the concepts of ligand-driven conformational diversity and selective tissue actions can be exploited in the future for drug development which selectively regulate orphan receptors from the nuclear receptor family.
References
Gronemeyer H: Control of transcription activation by steroid hormone receptors. FASEB J. 1992, 6: 2524-2529. Review
Leonhardt SA, Boonyaratanakornkit V, Edwards DP: Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids. 2003, 68: 761-770. 10.1016/S0039-128X(03)00129-6. Review
Conneely OM, Mulac-Jericevic B, Lydon JP: Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids. 68: 771-778. 10.1016/S0039-128X(03)00126-0. Review
Wardell SE, Edwards DP: Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs). Semin Reprod Med. 2005, 23: 9-21. 10.1055/s-2005-864030. Review
Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, Edwards DP, Hager GL: Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol. 2005, 25: 2406-2418. 10.1128/MCB.25.6.2406-2418.2005.
Conneely OM, Lydon JP: Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids. 2000, 65: 571-577. 10.1016/S0039-128X(00)00115-X. Review
Li X, O'Malley BW: Unfolding the action of progesterone receptors. J Biol Chem. 2003, 278: 39261-39264. 10.1074/jbc.R300024200. Review
Leonhardt SA, Boonyaratanakornkit V, Edwards DP: Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids. 2003, 68: 761-770. 10.1016/S0039-128X(03)00129-6. Review
Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW: Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res. 1997, 52: 141-164. Review
Chua SS, Ma Z, Ngan E, Tsai SY: Cdc25B as a steroid receptor coactivator. Vitam Horm. 2004, 68: 231-256. Review
Shupnik MA: Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene. 2004, 23: 7979-7989. 10.1038/sj.onc.1208076. Review
Agoulnik IU, Krause WC, Bingman WE, Rahman HT, Amrikachi M, Ayala GE, Weigel NL: Repressors of androgen and progesterone receptor action. J Biol Chem. 2003, 278: 31136-31148. 10.1074/jbc.M305153200.
Wang D, Simons SS: Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate. Mol Endocrinol. 2005, 19: 1483-1500. 10.1210/me.2005-0012.
Christian M, Pohnke Y, Kempf R, Gellersen B, Brosens JJ: Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Mol Endocrinol. 2002, 16: 141-154. 10.1210/me.16.1.141.
Zhang XL, Zhang D, Michel FJ, Blum JL, Simmen FA, Simmen RC: Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells. J Biol Chem. 2003, 278: 21474-21482. 10.1074/jbc.M212098200.
Hewetson A, Chilton BS: An Sp1-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene. J Biol Chem. 2003, 278: 40177-40185. 10.1074/jbc.M303921200.
Young KA, Stouffer RL: Gonadotropin and steroid regulation of matrix metalloproteinases and their endogenous tissue inhibitors in the developed corpus luteum of the rhesus monkey during the menstrual cycle. Biol Reprod. 2004, 70: 244-252. 10.1095/biolreprod.103.022053.
Di Nezza LA, Jobling T, Salamonsen LA: Progestin suppresses matrix metalloproteinase production in endometrial cancer. Gynecol Oncol. 2003, 89: 325-333. 10.1016/S0090-8258(03)00089-1.
Huang HF, Hong LH, Tan Y, Sheng JZ: Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril. 2004, 81: 1235-1239. 10.1016/j.fertnstert.2003.10.027.
Shimonovitz S, Hurwitz A, Hochner-Celnikier D, Dushnik M, Anteby E, Yagel S: Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. Am J Obstet Gynecol. 1998, 178: 457-461. 10.1016/S0002-9378(98)70420-X.
Goldman S, Shalev E: Difference in Progesterone Receptor Isoforms Ratio, Between Early and Late First Trimester Human Trophoblast, Is Associated with Differential Cell Invasion and Matrix Metalloproteinase2 (MMP2) Expression. Biol Reprod. 2006, 74: 13-22. 10.1095/biolreprod.105.044925.
Qin H, Sun Y, Benveniste EN: The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem. 1999, 274: 29130-29137. 10.1074/jbc.274.41.29130.
Mertens PR, Harendza S, Pollock AS, Lovett DH: Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem. 1997, 272: 22905-22912. 10.1074/jbc.272.36.22905.
Website title. [http://www.cbil.upenn.edu/tess]
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
Both authors conceived the hypothesis, S.G drafted the ms and ES edited the ms.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Goldman, S., Shalev, E. A proposed mechanism for progesterone regulation of trophoblast MMP2 transcription independent of classical progesterone response elements on its promoter . J Exp Clin Assist Reprod 3, 4 (2006). https://doi.org/10.1186/1743-1050-3-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1743-1050-3-4